Due to the role of RAD52 in DNA repair, changes in its expression or regulation caused by polymorphisms affecting the miRNA-binding sites may have a significant impact on the risk of HBV-associated HCC (66). This evidence concerns the gene RAD52 and hepatocellular carcinoma.